8 Mutually Exclusive Yes/No Checkbox Enforcement (All Binary Questions) Ensures that for each Yes/No question (e.g., other group plan coverage, transferred benefits, provincial application/approval, PAP enrollment, GLP-1 combination, dose exceeds 2.4 mg), exactly one option is selected
It comes with a label that says Reta. The efficacy story and the safety story are the same product in a trial
However, excess usage may cause gastrointestinal discomfort, fishy body odor (in sweat, breath, or urine), allergic reactions, stomach upset, diarrhea, and heartburn
In this case, the concern is whether semaglutide, while not a sulfa drug, might still cause a reaction because it has something in common with sulfa drugs